anophel
mosquito
aspir
gametocyt
infect
blood
gametocyt
develop
gamet
mosquito
intestin
blood
mosquito
microgamet
male
penetr
macrogamet
femal
form
zygot
cell
chang
elong
motil
ookinet
evolv
oocyst
oocyst
burst
sporozoit
releas
get
saliva
mosquito
entir
cycl
insid
mosquito
take
day
sporozoit
enter
human
bloodstream
saliva
mosquito
liver
cell
via
bloodstream
get
infect
penetr
liver
cell
turn
schizont
exoerythrocyt
cycl
except
p
oval
merozoit
releas
bloodstream
liver
cycl
exoerythrocyt
cycl
p
vivax
p
oval
produc
hypnozoit
stay
dormant
liver
cell
merozoit
enter
red
blood
cell
multipli
asexu
ruptur
erythrocyt
merozoit
releas
infect
erythrocyt
cycl
repeat
everi
day
blood
stage
parasit
respons
typic
malaria
symptom
merozoit
differenti
gametocyt
aspir
mosquito
mosquito
infect
pathogen
transfer
parasit
someon
els
possibl
tabl
fig
symptom
malaria
appear
incub
period
incub
period
vari
depend
pathogen
week
also
take
sever
month
even
year
p
vivax
occasion
p
oval
malaria
divid
three
differ
form
malaria
tertiana
pathogen
p
vivax
p
oval
fever
everi
second
day
one
day
without
fever
spontan
remiss
max
yearsmalaria
quartana
pathogen
p
malaria
fever
everi
third
day
day
without
fever
spontan
remissionmalaria
tropica
pathogen
p
falciparum
irregular
fever
due
lack
synchronis
parasit
reproduct
sever
form
malaria
malaria
maligna
high
fatal
recurr
year
fever
specif
pattern
first
hour
strong
rigor
increas
fever
typic
develop
fever
reach
durat
h
often
associ
flush
vomit
nausea
fever
stage
follow
approxim
stage
sever
sweat
decreas
fever
sever
form
malaria
fatal
within
day
caus
death
cerebr
malaria
respiratori
failur
adr
kidney
failur
main
reason
complic
cytoadher
bond
erythrocyt
result
failur
microcircul
follow
ischaemia
vital
organ
case
pyrexia
unknown
origin
patient
alway
ask
previou
stay
oversea
addit
symptom
blood
test
import
diagnost
tool
parasit
demonstr
use
blood
smear
thick
drop
singl
neg
smear
exclud
malaria
neg
smear
repeat
three
time
within
h
thick
drop
exist
parasit
low
count
accumul
detect
posit
test
number
parasit
erythrocyt
calcul
parasit
count
might
indic
complic
malaria
pcrtest
plasmodium
dna
good
diagnost
tool
commonli
use
slightli
sensit
blood
smear
also
allow
discrimin
malaria
speci
anoth
test
antigen
detect
immunolog
test
often
use
dipstick
cassett
format
provid
result
within
min
henc
refer
rapid
diagnost
test
rdt
rdt
follow
microscopi
rdt
smear
microscopi
current
provid
best
result
test
malaria
plasmodium
antibodi
test
suitabl
initi
phase
antibodi
detect
day
retrospect
confirm
previou
infect
regular
monitor
blood
count
renal
function
care
fluid
balanc
necessari
treatment
malaria
cxr
may
necessari
respiratori
symptom
present
treatment
depend
sever
pathogen
complic
malaria
admiss
intens
care
consid
one
follow
criteria
exist
inabl
oral
intak
medicationparasit
load
erythrocyt
sever
symptom
malaria
see
tabl
treatment
option
complic
malaria
artesun
allow
countri
mgkgbw
iv
first
dose
admiss
repeat
h
minimum
durat
therapi
h
day
till
oral
therapi
toleratedorcombin
quinin
doxycyclin
clindamycin
quinin
first
dose
mgkgbw
iv
h
mgkgbw
iv
min
subsequ
administr
mgkgbw
iv
hmainten
therapi
mgkgbw
iv
h
three
time
day
begin
h
complet
first
doseexempt
patient
receiv
three
dose
quinin
last
h
mefloquin
prophylaxi
last
h
receiv
mefloquin
treatment
last
day
doxycyclin
mg
iv
twice
daili
day
iv
oral
clindamycin
initi
dose
mgkgbwmainten
dose
mgbw
everi
h
day
iv
oral
clinic
improv
medic
chang
complet
cycl
oral
therapi
uncompl
malaria
quinin
doxycyclin
clindamycin
uncompl
malaria
handl
normal
ward
outpati
therapi
close
supervis
consid
follow
condit
parasit
load
erythrocyt
age
monthsno
comorbiditypregn
excluded
oral
medic
intakep
falciparum
excludedclin
stabl
medic
therapi
last
h
daili
blood
smear
necessari
treatment
follow
process
diseas
patient
discharg
hospit
continu
treatment
home
oral
therapi
toler
clinic
improv
achiev
parasit
count
decreas
week
month
discharg
blood
smear
repeat
primaquin
erad
therapi
approv
countri
drug
use
elimin
hypnozoit
dormant
form
malaria
parasit
occur
p
oval
p
vivax
primaquin
caus
haemolysi
defici
statu
prior
therapi
need
establish
erad
primaquin
requir
patient
defici
dose
mg
weekli
week
monitor
haemolysi
could
consid
children
methaemoglobinaemia
provok
give
primaquin
singl
dose
primaquin
mg
p
falciparum
p
malaria
p
knowlesi
given
sterilis
gametocyt
malaria
caus
p
vivax
p
oval
coinfect
parasit
suspect
treatment
mg
primaquin
twice
day
recommend
treatment
uncompl
malaria
artemeth
mg
lumefantrin
mg
four
tablet
appropri
dose
children
kg
one
tablet
kg
two
tablet
kg
three
tablet
follow
time
interv
h
p
falciparum
site
action
inhibit
nucleic
acid
protein
synthesisoratovaquon
mg
proguanil
mg
four
tablet
appropri
dose
children
kg
one
tablet
kg
two
tablet
kg
three
tablet
highfat
meal
milk
daili
day
p
vivax
papua
new
guinea
indonesia
p
falciparum
site
action
inhibit
metabol
enzym
thu
growth
parasiteormefloquin
first
dose
mg
second
dose
mg
h
first
dose
third
dose
mg
bw
kg
h
second
dose
p
falciparum
p
vivax
site
action
schizoidorchloroquin
dose
first
day
mgkgbw
second
day
mgkgbw
third
day
mgkgbw
p
malaria
p
knowlesi
p
falciparum
chloroquin
resist
site
action
erythrocyt
unknown
mechanismorchloroquin
primaquin
normal
chloroquin
dose
first
day
mgkgbw
second
day
mgkgbw
third
day
mgkgbw
site
action
erythrocytesprimaquin
mg
twice
day
day
adult
mgkgbw
daili
day
children
p
oval
p
vivax
countri
except
papua
new
guinea
indonesia
chloroquin
resist
site
action
extraerythrocyt
inhibit
plasmodium
mitochondria
combin
therapi
except
patient
prophylaxi
p
falciparum
p
vivax
papua
new
guinea
indonesia
quininsulfat
mg
children
mgkgbw
three
time
day
day
site
action
unknown
probabl
inhibit
plasmodium
dna
transcriptionrepl
doxycyclin
mg
twice
day
clindamycin
mg
children
mgkgbw
three
time
day
day
site
action
probabl
inhibit
dissoci
peptidyl
trna
ribosom
inhibit
protein
synthesi
bind
onto
ribosom
subunitorclindamycin
mgkgbw
three
time
daili
day
site
action
inhibit
protein
synthesi
bind
onto
ribosom
subunit
commenc
holiday
oversea
medic
advic
given
order
assess
malaria
risk
particular
countri
nearli
tropic
area
risk
get
infect
malaria
tourist
area
risk
might
small
infect
still
possibl
particular
day
trip
remot
area
pose
risk
area
malaria
outbreak
therefor
avoid
gener
mosquito
bite
avoid
minimis
risk
mosquitoborn
infect
mosquito
transmit
malaria
mainli
activ
night
sunris
sunset
howev
mosquito
bite
also
possibl
throughout
day
longsleev
shirt
long
pant
close
shoe
cover
skin
provid
protect
insect
bite
insect
repel
skin
cloth
offer
addit
protect
higher
concentr
offer
better
longer
protect
protect
period
normal
insect
repel
last
usual
h
slow
releas
product
prolong
effect
mosquito
avoid
aircondit
room
stay
air
condit
room
provid
certain
protect
spray
insecticid
room
surround
help
repel
minimis
quantiti
mosquito
bed
cover
mosquito
net
fig
chemoprophylaxi
import
main
caus
malaria
death
still
inadequ
chemoprophylaxi
differ
drug
chemoprophylaxi
avail
subject
travel
locat
parasit
resist
certain
drug
addit
differ
side
effect
dosag
cost
except
drug
chemoprophylaxi
malaria
taken
week
leav
countri
suffici
effect
primari
liver
stage
malaria
mefloquin
malaria
prophylaxi
without
absolut
contraind
pregnanc
chloroquin
schizontocid
mg
kgbw
mg
week
begin
week
enter
malariaendem
countri
week
return
advers
reaction
gastrointestin
photosensit
haemolysi
defici
neuropathi
longterm
treatment
cardiomyopathi
eye
damag
deposit
cornea
irrevers
retinopathi
narrow
therapeut
windowdoxycyclin
chemoprophylaxi
p
falciparum
mefloquin
resist
mgd
begin
day
enter
malariaendem
countri
week
return
advers
reaction
gastrointestin
photosensit
contraind
lactat
children
year
ageatovaquon
proguanil
mgd
adult
dose
children
weight
depend
begin
day
enter
malariaendem
countri
till
day
return
advers
reaction
gastrointestin
headach
vivid
dreamsmefloquin
mgweek
long
halflif
day
advers
reaction
gastrointestin
elev
transaminas
psychiatr
anxieti
agit
depress
vivid
dream
hallucin
seizur
suicid
ideat
avblock
bradycardia
leuco
thrombocytopenia
rash
alopecia
extrasystoli
contraind
dive
decreas
vigil
week
least
week
enter
malariaendem
countri
week
return
categori
b
medic
medic
malaria
without
absolut
contraind
pregnanc
use
first
trimest
consid
expect
benefit
justifi
potenti
risk
foetu
howev
recent
studi
suggest
even
first
trimest
medic
safe
take
dengu
viru
arboviru
four
differ
serotyp
denv
dengu
worldwid
distribut
tropic
subtrop
especi
asia
south
america
approxim
million
case
seriou
complic
per
year
occur
mortal
reduc
time
diagnosi
appropri
treatment
increas
risk
children
year
person
previou
dengu
infect
dengu
viru
transmit
aed
aegypti
mosquito
mosquito
mainli
bite
day
twilight
fig
incub
period
day
wide
rang
sever
dengu
symptom
major
infect
caus
minor
symptom
dengu
infect
also
quit
sever
tabl
particular
recurr
infect
dengu
associ
complic
sever
diseas
import
treat
doctor
rememb
initi
fever
critic
phase
follow
therefor
patient
must
monitor
close
time
diseas
goe
three
stage
fever
phase
day
sudden
high
fever
occasion
associ
bradycardia
myalgia
mainli
spine
arm
leg
breakbon
fever
headach
retrobulbar
pain
rigor
metallicbitt
tast
vomit
dehydrationcrit
phase
day
normal
temperatur
possibl
mild
fever
later
leucopenia
exanthema
petechia
lymphadenopathi
sever
dengu
abdomin
pain
spontan
bleed
volum
shift
periton
space
plasma
leak
pleural
effus
hepatomegali
cm
rapid
increas
haematocrit
decreas
thrombocyt
shock
dengu
haemorrhag
shock
dh
dengu
shock
syndrom
dss
increas
bleed
dengu
haemorrhag
fever
dhf
organ
failur
particularli
liver
remiss
day
last
sometim
week
risk
hyperhydr
given
extravascular
fluid
reabsorb
without
reduc
intraven
fluid
administr
particular
long
remiss
fatigu
depress
may
present
normal
longterm
damag
dengu
infect
vascular
chang
recov
complet
medic
avail
treat
dengu
directli
diagnosi
dengu
demonstr
pcr
initi
phase
use
igm
igg
day
later
due
sever
complic
haematocrit
coagul
paramet
leukocyt
platelet
test
daili
thrombocyt
rise
suspicion
dhf
pleural
effus
suspect
cxr
obtain
tighten
blood
pressur
cuff
petechia
provok
medium
pressur
systol
diastol
pressur
min
use
diagnost
tool
increas
haematocrit
pleural
effus
ascit
hypoproteinaemia
could
sign
extravascular
fluid
loss
extravascular
fluid
loss
typic
found
initi
phase
henc
fluid
replac
therapi
crucial
phase
extravascular
fluid
loss
come
end
quit
quickli
complic
fluid
replac
therapi
hyperhydr
decreas
haematocrit
fluid
administr
repres
fluid
excess
hyperhydr
henc
care
monitor
fluid
balanc
weight
necessari
therapi
adjust
accord
sever
necessari
dic
blood
loss
shock
requir
specif
treatment
like
dengu
chikungunya
mosquitoborn
diseas
speci
transmit
chikungunya
viru
chikv
aed
aegypti
tropic
subtrop
aed
albopictu
colder
region
fig
mosquito
bite
day
night
mainli
earli
morn
hour
late
afternoon
incub
period
day
symptom
similar
dengu
patient
suffer
sudden
fever
headach
skin
rash
fatigu
strong
limb
muscl
pain
affect
joint
often
swollen
symptom
gener
last
day
persist
week
year
diseas
longterm
effect
diagnosi
rtpcr
virolog
method
use
initi
phase
later
diagnos
igm
igg
igm
peak
week
detect
month
treatment
requir
analgesia
yellow
fever
diseas
transmit
mainli
aed
aegypti
mosquito
also
mosquito
tick
pathogen
rnacontain
flaviviru
approxim
infect
approxim
death
annual
case
occur
africa
remain
south
america
risk
get
infect
yellow
fever
africa
higher
south
america
fig
transmiss
occur
rainforest
area
jungl
sylvat
cycl
mosquito
transfer
viru
monkey
human
endem
area
savannah
savannah
intermedi
cycl
either
transfer
monkey
human
human
via
mosquito
urban
area
human
human
via
mosquito
incub
period
day
diseas
two
phase
acut
phase
come
fever
headach
myalgia
head
backach
loss
appetit
nausea
vomit
diarrhoea
second
phase
occur
approx
infect
human
within
next
h
jaundic
abdomin
pain
vomit
rapidli
develop
follow
diffus
bleed
epistaxi
gi
bleed
multiorgan
failur
mainli
kidney
symptom
sever
second
phase
develop
patient
die
within
next
day
patient
surviv
usual
recov
without
signific
organ
damag
diagnosi
made
via
blood
tissu
biopsi
liver
cure
yellow
fever
support
measur
taken
howev
effect
lifevaccin
avail
authoris
doctor
authoris
prescrib
give
vaccin
sever
side
effect
vaccin
sever
allerg
reaction
vaccineassoci
neurotrop
diseasepostvaccin
encephalopathi
vaccineassoci
viscerotrop
diseasemultiorgan
failur
travel
countri
yellow
fever
endem
vaccin
mandatori
side
effect
seem
agerel
occur
increasingli
progress
age
young
children
vaccin
contraind
children
month
pregnanc
analysi
yellow
fever
vaccin
advers
event
demonstr
increas
frequenc
seriou
advers
event
person
age
year
older
risk
viscerotrop
side
effect
year
popul
year
age
year
age
failur
vaccin
document
lead
refus
entri
countri
certain
time
quarantin
leav
area
yellow
fever
occur
clinic
indic
receiv
yellow
fever
vaccin
eg
children
month
poor
immun
statu
written
medic
exempt
grant
enabl
travel
countri
without
vaccin
absolut
contraind
yellow
fever
vaccin
allergi
vaccin
egg
proteinag
monthsimmunodeficiencyneoplasiatransplantationsimmunosuppress
therapi
rel
contraind
yellow
fever
vaccin
age
monthsag
hiv
infect
lymphocyt
total
children
year
age
pregnancylact
aed
aegypti
spread
also
zika
viru
howev
also
sexual
intrauterin
perinat
transmit
current
main
distribut
countri
south
north
america
well
caribbean
island
singapor
countri
south
pacif
island
symptom
zika
infect
may
fever
rash
arthralgia
myalgia
headach
conjunct
case
infect
asymptomat
symptom
last
sever
day
week
incub
period
day
like
day
week
diagnosi
made
via
pcr
serolog
blood
pcr
detect
first
week
diseas
urin
pcr
detect
viru
week
specif
treatment
avail
death
unlik
potenti
risk
pregnanc
microcephali
birth
defect
may
develop
zina
viru
cane
also
transfer
via
semen
affect
unborn
life
ross
river
viru
rrv
transmit
bite
culex
annulirostri
aed
vigilax
aed
normanensi
aed
notoscriptu
australia
papua
new
guinea
part
indonesia
western
pacif
island
main
transmiss
time
humid
summer
month
decemb
till
march
main
symptom
fever
rash
headach
myalgia
arthralgia
fatigu
initi
symptom
fever
last
usual
week
myalgia
arthralgia
usual
last
longer
symptom
fatigu
depress
late
complic
incub
time
day
week
diagnosi
made
igm
symptomat
treatment
avail
barmah
forest
viru
bfv
transmit
speci
rrv
mainli
found
australia
mani
peopl
develop
symptom
incub
time
day
symptom
appear
similar
one
rrv
initi
symptom
last
week
arthralgia
myalgia
may
last
month
diagnosi
made
igm
symptomat
treatment
avail
sindbi
viru
sinv
relat
chikungunya
viru
mainli
transmit
via
culex
culiseta
mosquito
found
europ
africa
asia
oceania
symptom
durat
symptom
quit
similar
rrv
bfv
diagnosi
made
igm
symptomat
treatment
avail
nyongnyong
viru
onnv
relat
chikungunya
viru
restrict
africa
similar
symptom
chikungunya
viru
addit
mainli
cervic
lymphadenopathi
affect
join
rare
show
sign
effus
reservoir
poultri
meal
prepar
eggincub
hsymptom
fever
vomit
nausea
diarrhoea
occasion
blood
mucou
stooldur
daystreat
symptomat
azithromycin
g
od
day
ciprofloxacin
mg
bd
day
ceftriaxon
g
od
reservoir
water
foodincub
weekssymptom
headach
myalgia
bradycardia
roseola
abdomin
area
continu
fever
porridg
like
diarrhoea
intestin
bleed
decreas
fever
weekstreat
symptomat
azithromycin
g
od
day
ciprofloxacin
mg
bd
day
ceftriaxon
g
od
vaccin
avail
reservoir
human
fli
food
faecesincub
dayssymptom
fever
diarrhoea
sometim
blood
mucu
stool
sever
abdomin
paintreat
symptomat
ciprofloxacin
bd
day
norfloxacin
mg
bd
day
bactrim
mg
bd
day
reservoir
food
waterincub
dayssymptom
mild
sever
diarrhoea
fever
blood
mucou
stool
common
caus
diarrhoea
overseastreat
symptomat
norfloxacin
mg
od
ciprofloxacin
mg
od
reservoir
food
particular
strawberri
waterincub
weekssymptom
diarrhoea
like
raspberri
jelli
fever
blood
mucou
stool
risk
develop
liver
abscesstreat
symptomat
asymptomat
carrier
paromomycin
mg
td
day
invas
tinidazol
g
od
day
metronidazol
mg
td
day
reservoir
contamin
food
waterincub
dayssymptom
often
mild
gi
symptom
develop
sever
symptom
nausea
vomit
rice
waterlik
diarrhoea
sever
dehydr
mortal
risk
treatment
rehydr
electrolyt
substitut
vaccin
avail
azithromycin
g
singl
dose
ciprofloxacin
g
singl
dose
reservoir
food
particular
sea
food
waterincub
dayssymptom
initi
phase
day
flulik
symptom
gastrointestin
hepatomegali
hepat
manifest
week
jaundic
approx
jaundic
dark
urin
jaundic
pruritu
hepat
chronic
form
rare
fatal
fatal
age
depend
treatment
symptomat
bed
rest
avoid
liver
toxic
substanc
alcohol
medic
vaccin
avail
japanes
enceph
caus
flaviviru
transmit
mosquito
culex
particularli
c
tritaeniorhynchu
host
usual
pig
water
bird
human
usual
suffici
high
concentr
viru
serv
host
distribut
asia
especi
rural
area
epidem
occur
everi
year
fig
transmiss
occur
throughout
year
frequent
peak
raini
season
case
per
year
patient
symptomat
howev
symptom
develop
mortal
rate
approx
patient
surviv
longterm
neurolog
psychiatr
complic
mild
cours
japanes
enceph
may
accompani
mild
fever
headach
sever
case
show
high
fever
neck
stiff
photophobia
headach
disorient
coma
convuls
spastic
paralysi
death
consequenti
damag
may
behaviour
disord
convuls
paralysi
speech
disord
diagnosi
establish
blood
test
lumbar
punctur
current
treatment
option
vaccin
usual
well
toler
avail
prophylaxi
three
main
condit
caus
pathogen
african
trypanosomiasi
sleep
sick
transmit
tsets
fli
distribut
countri
subsaharan
africa
seventi
percent
occur
democrat
republ
congo
tsets
fli
mainli
found
rural
area
two
form
caus
sleep
sick
brucei
rhodesiens
brucei
gambiens
brucei
gambiens
incub
period
month
year
brucei
rhodesiens
week
month
initi
phase
haemolyticlymphat
phase
pathogen
replic
tissu
blood
lymphat
tissu
symptom
intermitt
fever
headach
myalgia
pruritu
addit
painless
indur
chancr
skin
day
bite
lymphadenopathi
axillari
inguin
associ
second
phase
cn
affect
caus
continu
headach
behaviour
disord
mood
swing
depress
delirium
sensit
disord
coordin
problem
disrupt
sleep
cycl
daytim
somnol
diagnosi
mainli
made
clinic
b
rhodesiens
blood
test
centrifug
wet
prepar
detect
parasit
avail
examin
buffi
coat
increas
sensit
biopsi
lymph
node
detect
pathogen
diagnost
brunei
gambiens
use
cultur
pcr
card
agglutin
test
trypanosomiasi
catt
field
test
suitabl
mass
popul
screen
endem
area
b
gambiens
low
specif
henc
use
identifi
suspect
case
diagnos
patient
need
cerebrospin
fluid
examin
stage
influenc
treatment
option
tabl
treatment
depend
pathogen
stage
untreat
infect
form
lead
coma
death
leishmaniasi
three
form
viscer
cutan
mucos
kalaazar
differ
pathogen
approx
held
respons
diseas
diseas
transmit
mosquito
sandfli
phlebotomu
lutzomyia
cutan
form
common
one
caus
skin
ulcer
typic
form
appear
week
month
initi
mosquito
bite
initi
papul
form
later
ulcer
pain
painless
viscer
form
affect
organ
especi
liver
spleen
bone
marrow
therefor
form
quit
danger
chang
occur
within
month
year
hepatosplenomegali
pancytopenia
develop
mucu
form
rare
ulcer
chang
mucou
membran
eg
nose
mouth
throat
typic
endem
area
leishmaniasi
east
africa
arab
countri
india
bangladesh
brazil
south
american
countri
histor
diagnosi
made
take
biopsi
skin
bone
marrow
tissu
cultur
pcr
serolog
test
high
sensit
replac
biopsi
make
diagnosi
viscer
diseas
fatal
without
treatment
need
treat
case
form
requir
normal
treatment
follow
medic
avail
pentaval
antimoni
sbv
compound
mg
per
day
iv
im
day
liposom
amphotericin
b
mg
od
iv
day
miltefosin
adult
kg
mg
time
daili
day
azol
fluconazol
mg
od
week
itraconazol
mg
bd
day
ketoconazol
mg
od
least
day
paromomycin
uncommonli
use
pentamidin
isethion
uncommonli
use
chaga
diseas
transmit
via
insect
bite
kiss
bug
contamin
food
occur
central
south
america
acut
chronic
phase
acut
phase
within
week
infect
localis
swell
area
insect
bite
skin
mucou
membran
lymphadenopathi
bilater
orbit
oedema
meningoenceph
myocard
occur
infect
becom
chronic
caus
arrhythmia
risk
sudden
death
cardiomyopathi
enlarg
oesophagu
megaoesophagu
colon
megacolon
even
year
decad
cardiomyopathi
consist
fibros
myocard
caus
arrhythmia
rbbb
left
anterior
fascicular
block
st
chang
prematur
ventricular
beat
bradycardia
ventricular
failur
diagnosi
acut
phase
made
blood
smear
thick
thin
visualis
parasit
serolog
test
also
avail
treatment
recommend
acut
phase
patient
age
advanc
cardiomyopathi
chronic
chaga
diseas
tabl
age
group
benefit
risk
need
outweigh
kind
roundworm
found
tropic
subtrop
region
africa
southeast
asia
transfer
follow
oral
intak
egg
contamin
food
larva
enter
bloodstream
hatch
intestin
reach
lung
via
blood
penetr
lung
tissu
larva
cough
sputum
swallow
larva
reach
intestin
matur
within
next
month
lay
egg
excret
via
faec
adult
worm
live
year
infect
usual
asymptomat
howev
abdomin
pain
flulik
symptom
allerg
skin
manifest
malnutrit
product
cough
stridor
occur
diagnosi
made
examin
faec
egg
worm
sputum
larva
hookworm
found
tropic
subtrop
region
africa
latin
america
transmiss
percutan
oral
ingest
contamin
soil
contamin
soil
larva
abl
surviv
week
larva
penetr
skin
enter
blood
reach
alveoli
lung
ascend
airway
swallow
final
get
intestin
larva
matur
adult
worm
worm
attach
wall
intestin
feed
blood
egg
excret
faec
reach
soil
egg
surviv
year
common
symptom
pruritu
rash
entri
site
abdomin
pain
diarrhoea
weight
loss
anaemia
extrem
fatigu
diagnosi
made
faec
filariasi
worldwid
distribut
tropic
subtrop
region
caus
wuchereria
bancrofti
brugia
malayi
transmit
mosquito
infect
filariform
grow
insid
mosquito
enter
via
saliva
bite
migrat
lymphat
vessel
lymph
node
develop
adult
live
year
femal
worm
produc
microfila
circul
blood
absorb
mosquito
develop
within
week
infect
filariform
initi
symptom
later
lymph
oedema
extrem
genit
common
symptom
men
hydrocel
develop
skin
typic
swell
harden
elephantiasi
diagnosi
made
via
blood
detect
blood
smear
perform
night
larva
circul
blood
night
also
serolog
detect
antifilaria
avail
diagnosi
treatment
dec
drug
choic
concurr
diseas
loa
loa
onchocerciasi
contraind
dec
seriou
side
effect
encephalopathi
death
ivermectin
use
prophylaxi
therapi
schistosomiasi
found
tropic
subtrop
region
worldwid
addit
malaria
common
parasit
diseas
parasit
schistosoma
hous
freshwat
snail
expos
freshwat
region
infect
occur
egg
excret
urin
faec
host
hatch
optim
condit
releas
miracidia
miracidia
infect
freshwat
snail
develop
sporocyst
develop
cercaria
get
releas
water
penetr
skin
host
shed
tail
becom
schistosomula
migrat
liver
liver
matur
adult
pair
adult
worm
migrat
bowel
bladder
lay
egg
rash
swimmer
itch
may
develop
entri
site
skin
suprapub
pain
haematuria
abdomin
pain
myalgia
fever
swell
lymph
node
liver
spleen
enlarg
eosinophilia
addit
symptom
risk
bladder
cancer
increas
schistosomiasi
diagnosi
made
stool
urin
maximum
excret
egg
urin
pm
whipworm
worldwid
distribut
humid
tropic
egg
oral
absorb
via
soil
unwash
veget
fruit
whipworm
grow
larg
intestin
egg
excret
via
faec
soil
egg
pass
variou
stage
get
absorb
symptom
abdomin
pain
chronic
diarrhoea
nausea
vomit
inflamm
intestin
anaemia
eosinophilia
diagnosi
made
stool
sampl
treatment
infect
depend
parasit
tabl
leptospira
long
motil
spirochet
worldwid
distribut
infect
occur
commonli
tropic
subtrop
region
spread
infect
urin
enter
water
soil
leptospir
surviv
sever
week
month
infect
caus
contact
either
direct
contact
urin
bodi
fluid
except
saliva
well
contamin
soil
water
bacteria
enter
bodi
skin
mucou
membran
broken
skin
increas
risk
infect
increas
risk
heavi
rainfal
flood
incub
period
usual
day
rang
day
symptom
vari
greatli
usual
sudden
onset
headach
fever
chill
myalgia
nausea
vomit
diarrhoea
rash
jaundic
common
sign
first
phase
day
patient
recov
second
phase
weil
diseas
develop
renal
failur
ard
hepatomegali
jaundic
haemorrhag
mening
fatal
rate
untreat
symptom
persist
sever
month
treatment
either
doxycyclin
mg
bd
benzylpenicillin
g
qid
ceftriaxon
g
od
day
infect
caus
rickettsia
orienta
ehrlichia
neorickettsia
neoehrlichia
anaplasma
summaris
rickettsi
infect
rickettsia
divid
typhu
group
spot
fever
group
orienta
make
typhu
group
reservoir
found
mainli
anim
like
rodent
speci
found
fish
vector
commonli
tick
scrub
typhu
vector
larval
mite
other
flea
lice
vector
infect
occur
either
bite
vector
direct
contact
inocul
inhal
contamin
fluid
faec
clinic
present
vari
mild
symptom
headach
myalgia
abdomin
pain
cough
rash
rickettsi
infect
like
rocki
mountain
brazilian
spot
fever
mediterranean
spot
fever
scrub
typhu
endem
typhu
fatal
rate
diagnosi
made
clinic
serolog
treatment
start
earli
suspicion
serolog
report
take
quit
time
delay
treatment
may
fatal
doxycyclin
mg
bd
day
azithromycin
mg
od
first
day
mg
od
day
antibiot
choic
qfever
zoonosi
caus
protozoa
coxiella
burnetii
bacterium
quit
resili
due
sporelik
life
cycl
remain
virul
month
even
year
primari
reservoir
cattl
goat
sheep
wildlif
like
kangaroo
rat
cat
rare
transmit
tick
bite
ingest
unpasteuris
milk
dairi
product
incub
time
usual
week
rang
day
week
initi
acut
qfever
come
sudden
onset
high
fever
headach
retrobulbar
myalgia
chill
nonproduct
cough
sweat
symptom
settl
within
day
infect
howev
asymptomat
often
thrombocytopenia
abnorm
lft
found
complic
ard
endocard
meningoenceph
diagnosi
base
detect
phase
ii
phase
antibodi
igg
week
apart
initi
test
phase
ii
taken
end
first
week
ill
igm
igg
rise
almost
time
fourfold
rise
diagnost
initi
neg
titr
rule
qfever
seroconvers
occur
usual
day
almost
alway
present
day
pcr
test
use
first
week
antibiot
administr
howev
neg
pcr
result
rule
qfever
chronic
qfever
develop
result
endocard
aneurysm
osteomyel
hepat
neurog
mononeur
optic
neuriti
pulmonari
interstiti
fibrosi
pseudotumor
renal
glomerulonephr
diseas
chronic
qfever
usual
develop
shortli
infect
howev
chronic
endocard
may
come
appar
year
even
longer
chronic
fatigu
syndrom
describ
approx
typic
chronic
qfever
initi
igg
titr
increas
treatment
acut
qfever
doxycyclin
mg
bd
day
least
day
fever
subsid
clinic
improv
serolog
confirm
take
time
treatment
delay
earli
treatment
effect
prevent
sever
complic
chronic
qfever
month
doxycyclin
mg
bd
hydroxychloroquin
mg
td
recommend
standard
treatment
rabi
almost
worldwid
distribut
death
occur
africa
asia
children
year
age
dog
main
vector
asia
also
risk
transmiss
monkey
addit
diseas
like
lyssaviru
bat
fli
fox
transfer
rabi
transmit
bite
scratch
wound
also
inocul
saliva
onto
mucou
membran
eye
infect
anim
thorough
clean
wound
vaccin
within
hour
prevent
diseas
incub
period
usual
month
less
week
year
initi
symptom
includ
paraesthesia
wound
area
diseas
pass
two
form
hyperact
form
show
hyperact
manic
behaviour
paranoia
hallucin
delirium
hydrophob
occasion
aerophobia
trigger
extrem
pain
spasm
larynx
area
paralyt
form
characteris
slow
steadi
increas
paralysi
paralysi
begin
area
infect
diagnost
establish
anim
inflict
wound
tissu
sampl
anim
taken
brain
brainstem
cerebellum
diagnosi
human
difficult
unreli
investig
blood
antibodi
saliva
pcr
spinal
fluid
antibodi
skin
biopsi
rabi
antigen
avail
vaccin
immun
globulin
given
pregnanc
typic
side
effect
vaccin
headach
myalgia
malais
fatigu
nausea
treatment
potenti
infect
postexposur
prophylaxi
pep
includ
irrig
wound
minimum
min
wash
wound
water
soap
iodin
disinfect
substancesrabi
vaccinerabi
immunoglobulin
wound
area
within
day
first
vaccin
follow
data
record
rabi
vaccin
given
oversea
address
email
telephon
practic
hospitald
vaccinationsbatch
number
name
vaccin
manufacturerhow
mani
vaccin
givenappl
subcutan
intramuscular
inject
recommend
follow
approach
potenti
rabi
anim
contact
categori
feed
anim
touch
anim
lick
intact
skin
pepcategori
nibbl
unprotect
skin
minor
scratch
without
bleed
immedi
pep
rabi
vaccinationcategori
singl
multipl
bite
transderm
scratch
lick
open
wound
mucou
membran
contact
saliva
contact
bat
fruit
bat
instant
pep
rabi
vaccin
rabi
immunoglobulin
vaccin
rabi
recommend
travel
month
area
rabi
presentprofess
deal
bat
fruit
batsprofess
might
get
rabi
contact
eg
veterinari
surgeon
nurs
laboratori
worker
handl
object
rabi
lyssavirusaft
anim
contact
categori
preexposur
prophylaxi
prep
includ
three
vaccin
day
dose
ml
intramuscularli
subcutan
vaccin
last
year
followup
vaccin
postexposur
prophylaxi
pep
includ
four
vaccin
day
dose
ml
intramuscularli
immunocompromis
patient
receiv
five
vaccin
addit
vaccin
day
previou
vaccin
two
vaccin
recommend
day
exposur
recommend
chang
brand
manufactur
cours
vaccin
howev
possibl
particular
vaccin
avail
immunoglobulin
administ
first
vaccin
dose
iukgbw
immunoglobulin
prefer
given
proxim
wound
immunoglobulin
dilut
wound
larg
enabl
cover
entir
wound
area
immunoglobulin
recommend
first
vaccin
given
day
ago
prep
pep
complet
adequ
serolog
detect
vnab
titr
iuml
present
avoid
infect
anim
fed
bring
food
carri
item
like
handbag
water
bottl
etc
avoid
stay
rang
monkey
distanc
maintain
stray
cat
dog
middl
east
respiratori
syndrom
mer
caus
corona
viru
corona
virus
caus
mild
flulik
symptom
also
sever
symptom
like
sever
acut
respiratori
syndrom
sar
merscov
occur
mainli
arabian
peninsula
iran
jordan
kuwait
lebanon
oman
qatar
saudi
arabia
unit
arab
emir
yemen
intern
travel
spread
worldwid
recent
result
case
korea
mer
mortal
diseas
transmit
droplet
direct
contact
merscov
also
wide
rang
symptom
mild
common
cold
symptom
infect
upper
respiratori
tract
rapidli
progress
pneumon
respiratori
failur
septic
shock
multiorgan
failur
seem
merscov
low
virul
sinc
transmiss
occur
usual
close
contact
human
human
care
person
suffer
mer
camel
seem
origin
reservoir
mild
form
fever
mild
respiratori
symptom
mer
consid
close
contact
infect
peopl
exist
prior
symptom
mer
asymptomat
also
lead
respiratori
failur
death
typic
symptom
includ
fever
cough
short
breath
pneumonia
pneumon
often
associ
mer
sometim
gastrointestin
symptom
diarrhoea
vomit
occur
high
mortal
treatment
depend
sever
diseas
caution
contact
camel
affect
countri
taken
eat
insuffici
heat
camel
meat
milk
avoid
suspicion
mer
consid
individu
follow
risk
profil
fever
pneumoniapneumon
stay
endem
area
contact
symptomat
person
endem
area
within
day
onset
symptomsfev
pneumoniapneumon
hospitalis
endem
area
contact
camel
camel
product
endem
area
within
day
onset
symptomsfev
pneumoniapneumon
contact
mer
diseas
person
within
day
onset
symptomsclust
patient
especi
medic
personnel
sever
respiratori
symptom
unclear
aetiolog
tuberculosi
caus
acidresist
mycobacterium
tuberculosi
respons
tuberculosi
global
distribut
occur
frequent
countri
low
hygien
standard
tuberculosi
spread
around
globe
intern
travel
immigr
also
show
rise
rate
resist
convent
therapi
time
initi
infect
tuberculin
convers
take
approx
week
transmiss
caus
droplet
initi
infect
asymptomat
caus
unspecif
symptom
cough
night
sweat
loss
appetit
fatigu
erythema
nodosum
peopl
normal
immun
develop
symptom
tuberculosi
initi
infect
usual
turn
latent
tuberculosi
tuberculosi
affect
organ
approxim
latent
tuberculosi
reactiv
later
stage
immun
system
weaken
tuberculosi
three
stage
exud
stage
caseat
cavern
format
caseou
pneumoniaproduct
stage
tubercl
formationsecondari
chang
scar
calcif
complic
primari
infect
hilum
lymph
node
tuberculosi
pleurisi
miliari
tuberculosi
caseou
pneumonia
landouzi
sepsi
usual
peopl
immunodefici
diagnosi
made
tuberculin
skin
test
tstmendel
mantoux
day
strictli
intraderm
inject
substanc
indur
inject
site
measur
indur
mm
may
suggest
tuberculosi
consid
posit
test
either
patient
radiolog
proof
close
contact
someon
tuberculosi
symptom
tuberculosi
hiv
posit
suffer
immunodefici
indur
mm
consid
posit
patient
travel
countri
high
tb
preval
iv
drug
user
homeless
resid
nurs
home
prison
diabet
mellitu
silicosi
hodgkin
endstag
renal
failur
indur
mm
consid
evid
tuberculosi
without
risk
factor
symptom
tst
neg
first
week
infect
well
patient
suffer
miliari
tuberculosi
hodgkin
sarcoidosi
viral
infect
lower
immun
receiv
immunosuppress
therapi
high
age
falseposit
test
occur
multipl
tst
vaccin
tuberculosi
infect
mycobacteria
test
tb
gold
offer
altern
test
method
test
sensit
tst
higher
specif
moreov
test
confirm
test
affect
previou
bcgimmunis
consist
three
part
control
determin
mitogen
control
determin
abil
immun
respons
antigen
detect
detect
prior
infect
cxr
may
demonstr
cavern
hilar
lymph
node
diagnost
tool
exclud
tuberculosi
treatment
durat
uncompl
tuberculosi
month
complic
tuberculosi
month
tabl
combin
treatment
differ
drug
medic
tuberculosi
treatment
isoniazid
mgkgbw
max
mg
side
effect
elev
serum
transaminas
polyneuropathi
prophylaxi
avoid
side
effect
pyridoxin
mgdrifampicin
mgkgbw
max
mgd
side
effect
elev
serum
transaminas
cholestasi
anaphylaxi
thrombocytopenia
flu
syndromepyrazinamid
mgkgbw
max
mg
side
effect
elev
serum
transaminas
hepat
nausea
flush
myopathi
arthralgia
hyperurikaemiaethambutol
initi
mgkgbw
max
mgd
side
effect
retrobulbar
neuriti
vaccin
bcg
vaccin
recommend
due
side
effect
lack
efficaci
vaccin
given
day
travel
minimum
time
suffici
protect
week
tabl
diver
alert
network
dan
nonprofit
organis
diver
provid
medic
inform
articl
dive
insur
life
insur
travel
insur
also
offer
cours
support
research
dan
intern
hotlin
support
coordin
dive
accid
also
gener
medic
advic
oversea
european
underwat
baromed
societi
eub
european
organis
dive
hyperbar
medicin
provid
guidelin
hyperbar
treatment
train
medic
profession
hyperbar
medicin
german
organis
dive
hyperbar
medicin
gesellschaft
tauch
und
provid
guidelin
hyperbar
treatment
train
medic
profession
hyperbar
medicin
south
pacif
underwat
medicin
societi
spum
organis
dive
hyperbar
medicin
australia
provid
guidelin
hyperbar
treatment
train
medic
profession
hyperbar
medicin
undersea
hyperbar
medic
societi
uhm
organis
dive
hyperbar
medicin
unit
state
provid
guidelin
hyperbar
treatment
train
medic
profession
hyperbar
medicin
organis
german
recreat
diver
verband
deutscher
sporttauch
vdst
provid
dive
curs
inform
environment
issu
research
sportiv
dive
activ
emerg
hotlin
dan
europ
cda
padun
roseto
itali
tel
fax
emerg
contact
dan
intern
america
west
coloni
place
durham
nc
usa
tel
fax
medic
emergencyhotlin
edif
galleria
plaza
campina
sp
cep
brazil
offic
tel
emergencyhotlin
japan
marin
recreat
associ
kowaotamachi
bldg
otamachi
chrome
nakaku
yokohama
citi
kagawa
japan
offic
tel
f
ax
emergencyhotlin
asiapacif
po
box
ashburton
australia
offic
tel
fax
emergencyhotlin
insid
australia
outsid
australia
southern
africa
privat
bag
halfway
hous
midrand
south
africa
tel
sharecal
south
africa
int
fax
int
emergencyhotlin
insid
southern
africa
outsid
southern
africa
eub
webmast
eubsorggtuem
co
bgunfallklinik
professorkuentscherstr
murnau
tel
fax
st
kilda
road
melbourn
vic
us
highway
suit
north
palm
beach
fl
tel
fax
berlin
str
offenbach
tel
fax
cdc
wwwcdcgovdan
wwwdiversalertnetworkorgdan
europ
wwwdaneuropeorgemedicin
http
emedicinemedscapecomeub
wwweubsorggtuem
wwwgtuemorgth
rubicon
research
repositori
http
archiverubiconfoundationorgspum
wwwspumsorgauuhm
wwwuhmsorgvdst
wwwvdstdewho
wwwwhoint
